Page last updated: 2024-10-30

pyrrolidine-2,4-dicarboxylic acid and Apnea

pyrrolidine-2,4-dicarboxylic acid has been researched along with Apnea in 1 studies

pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
"5 nmol of L-glutamate into the caudal subretrofacial area produced apnea in eight of eight animals tested, and the duration of apnea was 27 +/- 2 s."3.69Respiratory effects produced by microinjection of L-glutamate and an uptake inhibitor of L-glutamate into the caudal subretrofacial area of the medulla. ( DaSilva, AM; Gillis, RA; McManigle, JE; Panico, WH, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McManigle, JE1
Panico, WH1
DaSilva, AM1
Gillis, RA1

Other Studies

1 other study available for pyrrolidine-2,4-dicarboxylic acid and Apnea

ArticleYear
Respiratory effects produced by microinjection of L-glutamate and an uptake inhibitor of L-glutamate into the caudal subretrofacial area of the medulla.
    European journal of pharmacology, 1995, Jul-14, Volume: 280, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Apnea; Blood Pressure; Cats; Cycloleucine; Dicarboxyl

1995